Aberrant concentrations of liver-derived plasma albumin mRNA in liver pathologies

Clinical Chemistry

Volumn 56, Issue 1, 2010, Pages 82-89

  Chan, Rebecca W Y ^a   Wong, John ^a   Chan, Henry L Y ^a   Mok, Tony S K ^a   Lo, Wyatt Y W ^a   Lee, Vincent ^a   To, Ka F ^a   Lai, Paul B S ^a   Rainer, Timothy H ^a   Lo, Y M Dennis ^a   Chiu, Rossa W K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA FETOPROTEIN; DNA; MESSENGER RNA; RNA;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; DONOR; ENZYME ACTIVITY; FEMALE; GENOTYPE; GRAFT RECIPIENT; HEPATITIS B; HUMAN; LIVER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; FEMALE; GENOTYPE; HUMANS; LIVER; LIVER DISEASES; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER; ROC CURVE; SERUM ALBUMIN;

EID: 73449089816     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2009.133355     Document Type: Article

References (39)

1. Lo YMD, Chiu RWK. The biology and diagnostic applications of plasma RNA [Review]. Ann N Y Acad Sci 2004;1022:135-9.
2. Chan AKC, Chiu RWK, Lo YMD. Cell-free nucleic acids in plasma, serum and urine: a new tool in molecular diagnosis. Ann Clin Biochem 2003;40: 122-30.
3. Anker P, Mulcahy H, Stroun M. Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies? Int J Cancer 2003;103:149 -52.
4. Lo YMD, Chiu RWK. Prenatal diagnosis: progress through plasma nucleic acids. Nat Rev Genet 2007;8:71-7.
5. Lo YMD, Tein MS, Pang CC, Yeung CK, Tong KL, Hjelm NM. Presence of donor-specific DNA in plasma of kidney and liver-transplant recipients [Letter]. Lancet 1998;351:1329 -30.
6. Lo YMD, Rainer TH, Chan LYS, Hjelm NM, Cocks RA. Plasma DNA as a prognostic marker in trauma patients. Clin Chem 2000;46:319 -23.
7. Chiu RWK, Rainer TH, Lo YMD. Circulating nucleic acid analysis: diagnostic applications for acute pathologies. Acta Neurochir Suppl 2005;95: 471-4.
8. Chan KCA, Chan AT, Leung SF, Pang JC, Wang AY, Tong JH, et al. Investigation into the origin and tumoral mass correlation of plasma Epstein-Barr virus DNA in nasopharyngeal carcinoma. Clin Chem 2005;51:2192-5.
9. Anker P, Stroun M. Progress in the knowledge of circulating nucleic acids: plasma RNA is particleassociated. Can it become a general detection marker for a cancer blood test? Clin Chem 2002; 48:1210 -1.
10. Chen XQ, Bonnefoi H, Pelte MF, Lyautey J, Lederrey C, Movarekhi S, et al. Telomerase RNA as a detection marker in the serum of breast cancer patients. Clin Cancer Res 2000;6:3823- 6.
11. Ng EKO, Tsui NBY, Lau TK, Leung TN, Chiu RWK, Panesar NS, et al. mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci U S A 2003;100:4748 -53.
12. Ng EKO, Leung TN, Tsui NBY, Lau TK, Panesar NS, Chiu RWK, et al. The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia. Clin Chem 2003;49:727-31.
13. Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 2001;61:1659-65.
14. Hillaire S, Barbu V, Boucher E, Moukhtar M, Poupon R. Albumin messenger RNA as a marker of circulating hepatocytes in hepatocellular carcinoma. Gastroenterology 1994;106:239-42.
15. Kar S, Carr BI. Detection of liver cells in peripheral blood of patients with advanced-stage hepatocellular carcinoma. Hepatology 1995;21:403-7.
16. Muller C, Petermann D, Pfeffel F, Oesterreicher C, Fugger R. Lack of specificity of albumin-mRNApositive cells as a marker of circulating hepatoma cells. Hepatology 1997;25:896 -9.
17. Barbu V, Bonnand AM, Hillaire S, Coste T, Chazouilleres O, Gugenheim J, et al. Circulating albumin messenger RNA in hepatocellular carcinoma: results of a multicenter prospective study. Hepatology 1997;26:1171-5.
18. Gion T, Taketomi A, Shimada M, Shirabe K, Hasegawa H, Takenaka K, et al. Perioperative change in albumin messenger RNA levels in patients with hepatocellular carcinoma. Hepatology 1998;28:1663- 8.
19. Peck-Radosavljevic M, Pidlich J, Bergmann M, Ferenci P, Seelos C, Wichlas M, et al. Preoperative TNM-classification is a better prognostic indicator for recurrence of hepatocellular carcinoma after liver transplantation than albumin mRNA in peripheral blood. Liver Transplant Oncology Group. J Hepatol 1998;28:497-503.
20. Wong IH, Leung T, Ho S, Lau WY, Chan M, Johnson PJ. Semiquantification of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction. Br J Cancer 1997; 76:628 -33.
21. Wong IH, Lau WY, Leung T, Johnson PJ. Quantitative comparison of alpha-fetoprotein and albumin mRNA levels in hepatocellular carcinoma/ adenoma, non-tumor liver and blood: implications in cancer detection and monitoring. Cancer Lett 2000;156:141-9.
22. Bastidas-Ramirez BE, Nuño-Gonzalez P, Vivas-Arceo C, Sánchez-Orozco LV, Panduro A. Albumin mRNA in peripheral white blood cells of cirrhotic patients with a superimposed alcoholic hepatitis is associated to fatal outcome. Hepatol Res 2002; 24:265.
23. Kudo Y, Ochi T, Shimada H, Ogawa S, Shinjo K. Utility of plasma circulating mRNA as a marker to detect hepatic injury. J Vet Med Sci 2008;70: 993-5.
24. Lambrechts AC, van 't Veer LJ, Rodenhuis S. The detection of minimal numbers of contaminating epithelial tumor cells in blood or bone marrow: use, limitations and future of RNA-based methods. Ann Oncol 1998;9:1269 -76.
25. Lui YYN, Chik KW, Chiu RWK, Ho CY, Lam CW, Lo YMD. Predominant hematopoietic origin of cellfree DNA in plasma and serum after sexmismatched bone marrow transplantation. Clin Chem 2002;48:421-7.
26. Lo YMD, Tsui NBY, Chiu RWK, Lau TK, Leung TN, Heung MMS, et al. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 2007;13:218 -23.
27. Chan RWY, Graham CA, Rainer TH, Lam NYL, Chiu RWK, Chik KW, et al. Use of a bone marrow transplantation model system to demonstrate the hematopoietic origin of plasma S100B mRNA. Clin Chem 2007;53:1874-6.
28. Chiu RWK, Poon LLM, Lau TK, Leung TN, Wong EM, Lo YMD. Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. Clin Chem 2001;47:1607-13.
29. Wong BCK, Chiu RWK, Tsui NBY, Chan KCA, Chan LW, Lau TK, et al. Circulating placental RNA in maternal plasma is associated with a preponderance of 5′ mRNA fragments: implications for noninvasive prenatal diagnosis and monitoring. Clin Chem 2005;51:1786 -95.
30. Chan HLY, Chui AK, Lau WY, Chan FK, Wong ML, Tse CH, et al. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation. J Med Virol 2002;68:182-7.
31. Loeb KR, Jerome KR, Goddard J, Huang ML, Cent A, Corey L. High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system. Hepatology 2000;32:626 -9.
32. Chan HL, Wong ML, Hui AY, Hung LC, Chan FK, Sung JJ. Use of hepatitis B virus DNA quantitation to predict hepatitis B e antigen reversion in chronic hepatitis B. J Clin Microbiol 2003;41: 4793-5.
33. Sherman M, Peltekian KM, Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 1995;22:432- 8.
34. Fournie GJ, Courtin JP, Laval F, Chale JJ, Pourrat JP, Pujazon MC, et al. Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Lett 1995;91: 221-7.
35. Fournie GJ, Martres F, Pourrat JP, Alary C, Rumeau M. Plasma DNA as cell death marker in elderly patients. Gerontology 1993;39:215-21.
36. Cheung ST, Fan ST, Lee YT, Chow JP, Ng IO, Fong DY, et al. Albumin mRNA in plasma predicts post-transplant recurrence of patients with hepatocellular carcinoma. Transplantation 2008;85: 81-7.
37. Heung MMS, Jin S, Tsui NB, Ding C, Leung TY, Lau TK, et al. Placenta-derived fetal specific mRNA is more readily detectable in maternal plasma than in whole blood. PLoS One 2009;4:e5858.
38. Chelly J, Concordet JP, Kaplan JC, Kahn A. Illegitimate transcription: transcription of any gene in any cell type. Proc Natl Acad Sci U S A 1989; 86:2617-21.
39. Heung MMS, Tsui NBY, Leung TY, Lau TK, Lo YMD, Chiu RWK. Development of extraction protocols to improve the yield for fetal RNA in maternal plasma. Prenat Diagn 2009;29:277-9.